Physician profile
Amanda Holcomb
NPI 1255954632
$3,034.90
in general payments reported to CMS, 2019-2025
9 companies · $1,915 in 2025
The $1,915 reported for 2025 was more than what 90% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $473 · 2023: $647 · 2025: $1,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,398 · Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,397.60 |
| Food and Beverage | $1,164.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $989.80 | 2022-2025 | Prostep, Ortholoc 2 Lapifuse, Anchorage |
| Arthrex, INC. | $935.74 | 2025 | |
| Elite Orthopedics, LLC | $700.82 | 2025 | |
| Abbvie INC. | $112.86 | 2022 | |
| Linvatec Corporation | $111.50 | 2023 | Fracture and Correction Colag 2, Colink Plating System |
| Medline Industries Lp | $72.41 | 2022 | |
| Treace Medical Concepts, INC. | $63.76 | 2025 | |
| Kerecis Limited | $31.20 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Averitas Pharma INC. | $16.81 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Holcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.